Reparel™ Knee Sleeve for Osteoarthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a special knee brace called the Reparel™ knee sleeve, which uses heat to help reduce pain and improve movement in people with knee pain. The study aims to see if this knee sleeve can help patients who have not found relief with other treatments or are not good candidates for surgery. The sleeve works by providing support and using warmth to ease pain and swelling. The Reparel™ knee sleeve is similar to other knee sleeves that have been studied for their ability to reduce pain and improve function in patients with knee pain.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, you cannot have had a corticosteroid injection in the knee for 90 days before joining the trial and cannot have one for 90 days after joining.
How does the Reparel Knee Sleeve treatment for osteoarthritis differ from other treatments?
What data supports the effectiveness of the Reparel Knee Sleeve treatment for osteoarthritis?
Who Is on the Research Team?
Amit Momaya, MD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for individuals with knee osteoarthritis confirmed by radiograph, who haven't had corticosteroid injections in the past 90 days and are choosing non-surgical treatments. It's not for those with prior knee surgery, both knees affected, unstable knees on exam, cancer in the knee area or hardware in the knee.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Reparel knee sleeve for treatment of knee osteoarthritis
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Reparel Knee Sleeve
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor